We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA: No Conclusive Link Between Sanofi’s Lantus and Cancer
FDA: No Conclusive Link Between Sanofi’s Lantus and Cancer
January 21, 2011
The FDA has determined that Sanofi-Aventis’ blockbuster diabetes drug Lantus cannot be linked conclusively with an increased risk of cancer.